Mechanical bowel preparation with or without oral antibiotics for rectal resection for cancer (REPCA trial): a study protocol for a multicenter randomized controlled trial
- PMID: 36151343
- DOI: 10.1007/s10151-022-02706-w
Mechanical bowel preparation with or without oral antibiotics for rectal resection for cancer (REPCA trial): a study protocol for a multicenter randomized controlled trial
Abstract
Background: There is still a lack of randomized trials assessing the clinical value of mechanical bowel preparation (MBP) and oral antibiotics (OA) before rectal surgery. Existing studies are inconsistent regarding OA. The aim of this study is to examine the role of MBP with or without OA (using Alfa Normix®) on postoperative complications in patients undergoing rectal resection for cancer.
Methods: We are conducting a prospective multicenter randomized controlled trial comparing MBP (Moviprep®) with OA (Alfa Normix®) versus MBP alone in patients undergoing elective rectal resection for cancer. Patients with rectal or rectosigmoid cancer are randomized in a 1:1 allocation ratio. The primary endpoint is incisional surgical site infection (SSI) assessed within 30 days after surgery. Secondary endpoints are anastomotic leakage (AL), organ/space SSI, other postoperative complications, intraoperative complications, operation time, bowel preparation quality, bowel preparation adherence. Intention-to-treat and per protocol analyses will be performed.
Conclusions: The results of the REPCA trial will demonstrate whether MBP + OA is superior to MBP alone in rectal cancer surgery. This trial might influence current preoperative practice and improve postoperative outcomes.
Keywords: Antibiotics; Mechanical bowel preparation; Rectal cancer; Surgical site infection.
© 2022. Springer Nature Switzerland AG.
References
-
- Aoyama T, Oba K, Honda M et al (2017) Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients’ data from three large phase III randomized trials. Cancer Med 6(7):1573–1580. https://doi.org/10.1002/cam4.1126 - DOI - PubMed - PMC
-
- Artinyan A, Orcutt ST, Anaya DA, Richardson P, Chen GJ, Berger DH (2015) Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg 261(3):497–505. https://doi.org/10.1097/SLA.0000000000000854 - DOI - PubMed
-
- Salvans S, Mayol X, Alonso S et al (2014) Postoperative peritoneal infection enhances migration and invasion capacities of tumor cells in vitro: an insight into the association between anastomotic leak and recurrence after surgery for colorectal cancer. Ann Surg 260(5):939–944. https://doi.org/10.1097/SLA.0000000000000958 - DOI - PubMed
-
- Agnes A, Puccioni C, D’Ugo D, Gasbarrini A, Biondi A, Persiani R (2021) The gut microbiota and colorectal surgery outcomes: facts or hype? A narrative review. BMC Surg 21(1):83. https://doi.org/10.1186/s12893-021-01087-5 - DOI - PubMed - PMC
-
- Grewal S, Reuvers JRD, Abis GSA et al (2021) Oral antibiotic prophylaxis reduces surgical site infection and anastomotic leakage in patients undergoing colorectal cancer surgery. Biomedicines 9(9):1184. https://doi.org/10.3390/biomedicines9091184 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
